Delivering future health solutions.
Health & Life Sciences
Major European Biomanufacturing cluster
Highest number of specialist hospitals outside of London
Home to the world renowned Liverpool School of Tropical Medicine
The highest concentration of Category Level 3 laboratories in the UK
There is no better validation of Liverpool’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality.
Latest Health & Life Sciences news
Diagnostics firm to open key biobank facility as part of £7.6m HQ investment
Liverpool COVID testing specialist, BioGrad, is to open the UK’s second largest biobank facility in the city.
Avison Young appointed as joint agent on Liverpool Science Park’s Cathedral View office scheme
Avison Young has been instructed as joint agent on Cathedral View, Liverpool Science Park’s (LSP’s) new, premium laboratory-enabled office scheme.
Sciontec promises cycling revolution as Hemisphere gets the green light at Paddington Village
Sciontec’s first new-build development, HEMISPHERE, has been granted planning permission, subject to the imminent formality of signing a standard Section 106 agreement.
Paddington Village’s Net Zero Hemisphere office tipped for approval
Liverpool City Council is recommended to greenlight Sciontec’s proposal for Hemisphere, a 172,000 sq ft office building that would be net zero in operation.
US biotech & Cancer treatment specialist firm launches new Liverpool laboratory
As part of a £60m-plus investment into groundbreaking cancer treatments Nashville-based Pierian Biosciences is opening a laboratory in Liverpool.
ALL UK FLU VACCINES THIS YEAR ARE MADE IN LIVERPOOL
If you are a UK resident and you are getting the flu vaccine this year it will have been produced and manufactured in Liverpool.
Sciontec reveals plans for £2m investment in Sensor City
Sciontec Developments Limited (Sciontec) is in the latter stages to transfer the ownership of Sensor City.